This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Exosomes Europe
4-5 November 2025
Amsterdam Marriott HotelAmsterdam, Netherlands

Dr. Payam Tamizi
Chief Executive Officer at Packard Medical
Speaker

Profile

Dr Payam Tamizi is a Mechanical Engineer and Business Leader with over a decade of international experience at the intersection of technology, healthcare, and business innovation. He holds an MBA from the University of Würzburg (Germany) and a Doctorate in Business Administration from the University of Côte d’Azur (France). His current work focuses on Advanced Therapy Medicinal Products (ATMPs), including cell and gene-based therapies and regenerative medicine. Dr Payam Tamizi has also completed professional courses in Stem Cell Medicine Harvard Medical School, 2025 and Essential and Professional Cell Culture Techniques in Royan Institute, Dr Tamizi’s career is distinguished by his commitment to translating scientific discovery into investment‐ready innovation, fostering growth in high‐impact healthcare technologies through strategic leadership, interdisciplinary collaboration, and a global perspective.

Agenda Sessions

  • Exosome Commercialization Pathways: Turning Biological Complexity into Scalable Business Models

    10:10
  • PANEL DISCUSSION: Stronger Together: Maximizing Impact Through Strategic Academic, Industry & Vendor Partnerships

    11:40